DK0825857T3 - Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse - Google Patents
Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelseInfo
- Publication number
- DK0825857T3 DK0825857T3 DK96913852T DK96913852T DK0825857T3 DK 0825857 T3 DK0825857 T3 DK 0825857T3 DK 96913852 T DK96913852 T DK 96913852T DK 96913852 T DK96913852 T DK 96913852T DK 0825857 T3 DK0825857 T3 DK 0825857T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- mania
- gabapentin
- derivatives
- bipolar disorder
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 4
- 208000020925 Bipolar disease Diseases 0.000 title abstract 2
- 206010026749 Mania Diseases 0.000 title abstract 2
- 229960002870 gabapentin Drugs 0.000 title abstract 2
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000306 recurrent effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Beans For Foods Or Fodder (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/440,570 US5510381A (en) | 1995-05-15 | 1995-05-15 | Method of treatment of mania and bipolar disorder |
| PCT/US1996/005898 WO1996036328A1 (en) | 1995-05-15 | 1996-04-26 | A method of treatment of mania and bipolar disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0825857T3 true DK0825857T3 (da) | 2002-09-30 |
Family
ID=23749281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96913852T DK0825857T3 (da) | 1995-05-15 | 1996-04-26 | Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5510381A (da) |
| EP (1) | EP0825857B1 (da) |
| JP (1) | JPH11505244A (da) |
| AT (1) | ATE218857T1 (da) |
| AU (1) | AU702435B2 (da) |
| CA (1) | CA2215923C (da) |
| CZ (1) | CZ288072B6 (da) |
| DE (1) | DE69621799T2 (da) |
| DK (1) | DK0825857T3 (da) |
| EE (1) | EE03420B1 (da) |
| ES (1) | ES2177783T3 (da) |
| GE (1) | GEP20002014B (da) |
| HU (1) | HUP9802087A3 (da) |
| NO (1) | NO315967B1 (da) |
| NZ (1) | NZ307366A (da) |
| PT (1) | PT825857E (da) |
| SK (1) | SK281982B6 (da) |
| WO (1) | WO1996036328A1 (da) |
| ZA (1) | ZA963826B (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372792B1 (en) | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
| EP0934061B3 (en) | 1996-07-24 | 2015-01-21 | Warner-Lambert Company LLC | Isobutylgaba and its derivatives for the treatment of pain |
| US6294690B1 (en) | 1997-10-07 | 2001-09-25 | Warner-Lambert Company | Process for preparing a cyclic amino acid anticonvulsant compound |
| ATE323067T1 (de) | 1997-10-27 | 2006-04-15 | Warner Lambert Co | Zyklische aminosäuren und deren derivate als arzneimittel |
| WO1999059572A1 (en) * | 1998-05-15 | 1999-11-25 | Warner-Lambert Company | Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| CA2327285C (en) | 1998-05-15 | 2005-06-14 | Warner-Lambert Company | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| JP2002516312A (ja) | 1998-05-26 | 2002-06-04 | ワーナー−ランバート・カンパニー | カルシウムチャンネルのα２δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物 |
| BR9911887A (pt) * | 1998-07-09 | 2001-03-27 | Warner Lambert Co | Método para o tratamento da insÈnia |
| WO2000023067A1 (en) * | 1998-10-16 | 2000-04-27 | Warner-Lambert Company | Method for the treatment of mania and bipolar disorder |
| JP2003525207A (ja) | 1999-06-02 | 2003-08-26 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 薬剤として有用なアミノ複素環 |
| AP2002002501A0 (en) * | 1999-10-07 | 2002-06-30 | Warner Lambert Co | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. |
| CA2411787C (en) * | 2000-06-16 | 2007-03-20 | Teva Pharmaceuticals Industries Ltd. | Stable gabapentin having ph within a controlled range |
| NZ522480A (en) * | 2000-06-26 | 2005-06-24 | Warner Lambert Co | Gabapentin analogues for sleep disorders |
| US20030119908A1 (en) * | 2001-12-21 | 2003-06-26 | Zambon Group S.P.A. | Stable gabapentin compositions |
| ITMI20012750A1 (it) | 2001-12-21 | 2003-06-21 | Procos Spa | Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura |
| CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| EP2575798B1 (en) | 2010-06-01 | 2017-08-09 | Rubicon Research Private Limited | Gastroretentive dosage forms of gaba analogs |
| WO2015144825A1 (en) | 2014-03-27 | 2015-10-01 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Oral liquid pharmaceutical solution of gabapentin |
| US11670410B1 (en) * | 2022-04-13 | 2023-06-06 | Green Sky Creations LLC | Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| US4355044A (en) * | 1980-12-19 | 1982-10-19 | Bernardo Heller | D-Phenylalanine treatment |
| US5084479A (en) * | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
| US5086072A (en) * | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| US5025035A (en) * | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
-
1995
- 1995-05-15 US US08/440,570 patent/US5510381A/en not_active Expired - Fee Related
-
1996
- 1996-04-26 AU AU56689/96A patent/AU702435B2/en not_active Ceased
- 1996-04-26 DE DE69621799T patent/DE69621799T2/de not_active Expired - Fee Related
- 1996-04-26 JP JP8534854A patent/JPH11505244A/ja not_active Ceased
- 1996-04-26 AT AT96913852T patent/ATE218857T1/de not_active IP Right Cessation
- 1996-04-26 GE GEAP19964027A patent/GEP20002014B/en unknown
- 1996-04-26 CA CA002215923A patent/CA2215923C/en not_active Expired - Fee Related
- 1996-04-26 SK SK1528-97A patent/SK281982B6/sk unknown
- 1996-04-26 EP EP96913852A patent/EP0825857B1/en not_active Expired - Lifetime
- 1996-04-26 DK DK96913852T patent/DK0825857T3/da active
- 1996-04-26 EE EE9700302A patent/EE03420B1/xx not_active IP Right Cessation
- 1996-04-26 WO PCT/US1996/005898 patent/WO1996036328A1/en not_active Ceased
- 1996-04-26 CZ CZ19973558A patent/CZ288072B6/cs not_active IP Right Cessation
- 1996-04-26 NZ NZ307366A patent/NZ307366A/en unknown
- 1996-04-26 ES ES96913852T patent/ES2177783T3/es not_active Expired - Lifetime
- 1996-04-26 HU HU9802087A patent/HUP9802087A3/hu unknown
- 1996-04-26 PT PT96913852T patent/PT825857E/pt unknown
- 1996-05-14 ZA ZA963826A patent/ZA963826B/xx unknown
-
1997
- 1997-11-14 NO NO19975234A patent/NO315967B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO975234L (no) | 1997-11-14 |
| US5510381A (en) | 1996-04-23 |
| EE9700302A (et) | 1998-06-15 |
| AU702435B2 (en) | 1999-02-18 |
| JPH11505244A (ja) | 1999-05-18 |
| CA2215923C (en) | 2001-10-09 |
| SK281982B6 (sk) | 2001-09-11 |
| ATE218857T1 (de) | 2002-06-15 |
| SK152897A3 (en) | 1999-05-07 |
| MX9707269A (es) | 1997-11-29 |
| CA2215923A1 (en) | 1996-11-21 |
| ZA963826B (en) | 1996-11-21 |
| DE69621799T2 (de) | 2003-01-02 |
| PT825857E (pt) | 2002-11-29 |
| CZ355897A3 (cs) | 1998-02-18 |
| AU5668996A (en) | 1996-11-29 |
| WO1996036328A1 (en) | 1996-11-21 |
| NZ307366A (en) | 1999-10-28 |
| NO975234D0 (no) | 1997-11-14 |
| NO315967B1 (no) | 2003-11-24 |
| CZ288072B6 (cs) | 2001-04-11 |
| DE69621799D1 (de) | 2002-07-18 |
| EE03420B1 (et) | 2001-06-15 |
| HUP9802087A3 (en) | 1999-08-30 |
| EP0825857A1 (en) | 1998-03-04 |
| EP0825857B1 (en) | 2002-06-12 |
| GEP20002014B (en) | 2000-04-10 |
| HUP9802087A2 (hu) | 1998-12-28 |
| ES2177783T3 (es) | 2002-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9700302A (et) | Meetod maania ja bipolaarse häire raviks | |
| CY1106020T1 (el) | Χρηση αναλογων caba για την βιομηχανικη κατασκευη ενος φαρμακου για την θepαπεια μανιας και διπολικων διαταραχων | |
| NO20053106D0 (no) | Oral, analgesisk doseringsform med forlenget frigivelse. | |
| ATE234092T1 (de) | 2-alkylpyrrolidine | |
| DE69526893D1 (de) | Stiftförmige Vorrichtung zur Verabreichung von Medikamenten mit unterschiedlich inkrementierter Dosierskala | |
| ATE193647T1 (de) | Di- und trivalente kleine moleküle als selektininhibitoren | |
| ATE252885T1 (de) | Plan zur verabreichung von h+, k+-atpase inhibitoren | |
| DE69432984D1 (de) | Therapeutische substituierte guanidine | |
| ATE275966T1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
| FI955260L (fi) | Transdermaalisia terapeuttisia systeemejä serotoniiniagonistien antamista varten | |
| BR9915460A (pt) | Método de tratamento de febre hemorrágica virótica | |
| YU42298A (sh) | Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola | |
| BR0016941A (pt) | Derivados de aminometil-fenil-ciclohexanona | |
| FI901876A0 (fi) | Ofullstaendiga hepadnavirus, vaccin producerande cellinjer samt terapi av leversjukdomar. | |
| ATE211383T1 (de) | Topische aciclovir-zubereitung | |
| NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
| ATE227997T1 (de) | Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid | |
| NO981320L (no) | Oral anvendelse av (+)-O-demetyltramadol som smertemiddel | |
| YU40098A (sh) | Upotreba olanzapina za dobijanje leka | |
| DE59712215D1 (de) | Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination | |
| ES2139382T3 (es) | Sistema terapeutico percutaneo para compuestos de silatran. | |
| MX9801515A (es) | Preparado de combinacion para la aplicacion en la demencia. | |
| DE59405654D1 (de) | T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen | |
| SE9303060L (sv) | Löstagbar stoppanordning |